Can I Take Plaquenil if I Already Have Macular Degeneration?

Hydroxychloroquine is a disease-modifying antirheumatic drug used for autoimmune conditions such as lupus and rheumatoid arthritis, and it can reduce pain and swelling and help prevent joint damage. ¹ It is thought to work by interfering with communication in the immune system, and it does not strongly suppress the immune system. ¹ For many people with lupus or rheumatoid arthritis, it is a cornerstone treatment that keeps the disease calm.

The concern with long-term use is a rare effect on the retina, the light-sensing layer at the back of the eye. In rare cases hydroxychloroquine can affect the retina and cause vision changes or loss of vision, a risk that is higher with high doses, older age, kidney or liver disease, or existing retinal problems. ¹ Any eye damage from hydroxychloroquine is usually not reversible, which is exactly why regular screening matters. ² Caught early, changes can prompt a plan change before central vision is affected.

Because both conditions target the macula, telling them apart on an eye scan takes extra care. Pre-existing retinal or macular disease is one of the recognized factors that raise the risk of hydroxychloroquine retinopathy. ³ It also makes screening results harder to read, since changes from macular degeneration and changes from the drug can look similar. That is not a reason to panic, but it is the reason your eye doctor will want a clear baseline and closer follow-up.

A baseline eye exam is advised near the start of hydroxychloroquine therapy, both to document your macular degeneration and to give a reference for future comparison. ³ With existing macular degeneration, that baseline is especially valuable, because it lets your eye doctor tell later whether a change is from your macular degeneration or from the medicine. Ask that your baseline scans be saved so every future visit has something to measure against.

Two specialists share this decision, so make sure they share information. Your rheumatologist manages the reason you need the drug, and your eye doctor watches your retina. Tell each one that you have macular degeneration and that you are considering or taking Plaquenil. When both doctors have the full picture, they can set a dose and a screening schedule that fit you, rather than working from half the story.

The American Academy of Ophthalmology advises keeping the daily hydroxychloroquine dose at or below 5.0 mg per kilogram of body weight to lower the risk of retinopathy. ³ Ask what your dose works out to for your weight, and how often you will be screened given your macular degeneration. Settling these numbers at the consultation, in plain terms you understand, is one of the most useful things you can do for your long-term eye safety.

No. Macular degeneration is usually a reason for closer eye monitoring, not an automatic ban. Pre-existing macular disease is listed among the risk factors for hydroxychloroquine retinopathy, so you should tell your doctor about it before starting. ³ Your rheumatologist and eye doctor then weigh the benefit for your autoimmune disease against the eye risk, and often the answer is that you can take it with careful baseline testing and regular screening.

Plaquenil does not cause typical age-related macular degeneration, but it can rarely cause its own separate retinal damage. At recommended doses, serious eye problems from hydroxychloroquine are rare. ¹ The practical worry is that both conditions affect the macula, so change needs careful tracking. Regular screening with your existing baseline scans lets your eye doctor tell the two apart and step in early if the medicine is contributing.

Often you would not notice early on, which is why screening exists. Macular OCT and wide-pattern fundus autofluorescence are recommended as the primary tests to detect hydroxychloroquine retinopathy before symptoms appear. ³ Still, report blurred vision, flashes, floaters, or other vision changes promptly. ² The combination of routine scans and reporting new symptoms is what protects your central vision most reliably.

The American Academy of Ophthalmology advises keeping the daily dose at or below 5.0 mg per kilogram of real body weight to lower retinopathy risk. ³ Most adults take between 200 mg and 400 mg per day. ¹ Ask your doctor what your weight-based limit is. Staying at or below that dose is one of the clearest ways the risk to your retina is kept low over years of treatment.

A baseline exam is advised near the start, with annual screening that may be deferred in the first 5 years only when there are no significant risk factors. ³ Because macular degeneration is a risk factor, you will likely need screening earlier and every year. Your eye doctor sets the exact schedule based on your macular degeneration, your dose, and your other risk factors, so ask them to spell out your personal timeline.

Hydroxychloroquine retinopathy is generally not reversible except possibly at its very earliest stages. ³ That sounds frightening, but it is precisely why screening is built to catch change early, when stopping or adjusting the drug can prevent further loss. The goal of every scheduled scan is to find a subtle sign long before it becomes something you would notice in daily life, so acting early keeps the risk small.